SURVEY-TO-EARNREAD THE CROWDANONYMIZED · CONSENT-FIRST

Season 2 candidate preview — not a launch or delivery commitment. Sample sizes, prices and timing are illustrative, pending qualified-panel measurement, safety tests, legal review and an approved contract.

All samples
EXAMPLEEvery number on this page is a format placeholder (00%, n=0,000). It is not real data and must not be quoted. The first real issue is published only after a 4-week re-measurement following the Season 2 input-quality update.

① One-page result report

Savior of Health Study · Result report

○○ brand — sleep-supplement perceptions in Southeast Asia · EXAMPLE

Valid n=000 (recruited 000 → excluded: attention check 00, screened out 00, under 18 / age unknown 00) · period ○○–○○

Q. Most important factor when buying a sleep supplement

All25–3435–44
Ingredients00%00%00%
Price00%00%00%
Brand trust00%00%— (suppressed)
Perception gap

"Share of people around you taking a sleep supplement": guessed 00% vs reported 00% → gap +00pp

Quality

Attention-check pass 00% · median time 0m 00s · 0 cells suppressed

EXAMPLE · not real data · do not cite

② Proposal template

[Proposal] Savior of Health Study

○○○ study

Proposal no.: SoH-ST-2026-○○○ · Issued: ○○ · Valid: 14 days
Supplier: [Entity / registration no. / contact — after incorporation]
To: [Client] / [Contact]

1. Objective

Decision question: (e.g.) "Which message should lead the ○○ launch in Vietnam?"

Out of scope: clinical efficacy, market sizing, individual-level analysis

2. Population

Region / country:   (country targeting if available, otherwise region)

Age: 18–  (Korean residents, medical/beauty questions: 19+)

Gender: [all/female/male] · Screener: (e.g.) "bought ○○ in the last 3 months" → qualifiers only

Panel grade: A+B (Eval: A only)

3. Questionnaire

Questions:   (screener + core + 1 attention check + 1 perception-gap guess)

Sensitive questions go through a per-campaign consent screen.

Review: automated lint (medical-ad terms, institution names, promo/booking links) + human review

4. Sample & quality

Valid n = [300/500/1,000] (recruited with a 15% oversample)

Valid = grade A/B, passed attention check, not screened out, aged 18+

If short: free top-up or pro-rata reduction (client chooses)

5. Deliverables

1–3 page summary (PDF) · cross-tab CSV (age band × gender × region, up to 3 dimensions)

Quality appendix: valid n, exclusions by reason, attention pass rate, time distribution, suppressed cells

Cells under 10 people (20 for sensitive cuts) shown as "—"

Never provided: respondent-level rows, verbatim free text, identifiers

6. Schedule (business days, D = questions final)

Schedule unconfirmed: question review → fieldwork → quality/disclosure review → delivery. Dates require capacity measurement and an approved contract.

7. Price (excl. VAT)

ItemQtyUnitAmount
Study [Lite/Standard/Pro]1₩450,000 (KRW) / ₩850,000 (KRW) / ₩1,600,000 (KRW)
Targeting condition[ ]₩150,000 (KRW)
+5 questions[ ]₩100,000 (KRW)
Season 2 beta discount−20%
Total

Payment: 50% on signing, 50% on delivery · KR tax invoice / overseas USD invoice at the quote-date reference rate

8. Usage limits (contract annex)

  • No use in advertising claims (efficacy, rankings, "No.1 satisfaction")
  • No attempt to re-identify or contact respondents
  • For academic publication, research-ethics (IRB) responsibility lies with the client
  • Medical institutions: agree to remain unnamed

9. Sign-off

Supplier [signature/date] · Client [signature/date]